case_images: PMC10196382_01
case_images: Images from computerized tomography (CT), FDG-PET and bone scintigraphy, showing bone relapse in right acetabulum (A), tenth right rib (B) and right frontal bone (C).
case_images: fonc-13-1158981-g001.jpg
case_images: PMC10196382_01_fonc-13-1158981-g001.jpg
case_images: f1
case_images: Whole-body positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) revealed pathological deposits of radiotracer, with high metabolic activity, in the right frontal bone, corresponding with the biopsied lesion, the right acetabulum and the tenth right rib, all of which were suggestive of tumor viability ( Figure 1 ), as well as two non-specific liver nodular lesions.
case_images: MRI study showing two liver metastases in January 2017 (A). Complete response of liver lesions after 2 cycles of talazoparib in April 2017 (B).
case_images: fonc-13-1158981-g002.jpg
case_images: PMC10196382_01_fonc-13-1158981-g002.jpg
case_images: f2
case_images: In April 2017, bone scintigraphy and liver MRI showed no evidence of disease ( Figure 2 ).
case_images: Timeline of the case.
case_images: fonc-13-1158981-g003.jpg
case_images: PMC10196382_01_fonc-13-1158981-g003.jpg
case_images: f3
case_images: A timeline of the case is presented in  Figure 3 .